Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Eton raises $20.1mm via Series A financing

Executive Summary

Eton Pharmaceuticals Inc. raised $20.1mm through its Series A financing of 6.9mm preferred shares at $3 each. The company is developing therapies using the FDA’s 505(b)(2) regulatory pathway. Eton is focused on liquid dosage forms including injectables, oral liquids, and ophthalmics.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register